Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company, has seen its shares rally premarket after announcing the pricing of its underwritten public offering.
Viridian is selling approximately 6.2 million shares at a public offering price of $11.00 per share and 23,126 shares of series B preferred stock for $733.37 per share, which are convertible into approximately 1.5 million shares of common stock.
The company has also granted the underwriters a 30-day option to purchase an additional 1.6 million shares of common stock at the public offering price. Jefferies, SVB Leerink and Evercore ISI are acting as joint book-running managers for the offering.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Viridian expects to raise around $85 million.
The firm intends to use the proceeds to advance its VRDN-001 and VRDN-002 programs and the preclinical development of its VRDN-004 and VRDN-005 programs as well as working capital and general corporate purposes.
Viridian shares are up 29.28% premarket at $13.82.
Should You Invest in Viridian Therapeutics Shares?
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
